If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 End-stage Renal Disease

Renal Transplant Candidates Need Not Be Concerned About a Living Donor's Age

May 15, 2012

For most patients with end-stage renal disease patients (ESRD), the age of a living donor (ranging from 18-64 years) has an insignificant effect on the long-term health of a transplanted kidney, according to researchers in British Columbia, Canada.
 

Rapid Anemia Management May Reduce Hospital Readmission Rates

May 12, 2012

NATIONAL HARBOR, Md.—Rapid anemia management (RAM) for patients with end-stage renal disease within seven days of hospital discharge decreases their rate of readmission, according to findings presented at the National Kidney Foundation 2012 Spring Clinical Meetings.
 

Hospitalized ESRD Patients Face Long Hemoglobin Recovery Time

May 12, 2012

NATIONAL HARBOR, Md.—Nearly two thirds of patients with end-stage renal disease (ESRD) experience a drop in hemoglobin (Hb) level after hospitalization, and it may take months after hospitalization for Hb levels to recover, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.
 

High Protein Intake May Elevate Levels of Advanced Glycation End Products

, May 01, 2012

Advanced glycation end products (AGEs) are byproducts of non-enzymatic chemical reactions between sugars and amino acids, lipids, or DNA.
 

FDA Puts Artificial Kidney on Fast Track for Approval

April 19, 2012

The FDA will be piloting three products for the treatment of end-stage renal disease (ESRD), including an artificial kidney, as part of an ongoing program to expedite the availability of medical technology.
 

The Impact of Bundling on Clinical Practice

March 22, 2012

This is the title of a scheduled May 12 session (3:30-5:00 p.m.) at the National Kidney Foundation's 2012 Spring Clinical Meetings, which is being held at the Gaylord National in National Harbor, Md., May 9-13.
 

Not All ESRD Patients May Want Dialysis

February 13, 2012

For some, freedom from the hassles of treatment is worth a shorter life expectancy, study finds.
 

Exercise Enhances Body Composition, Nutritional Status in Dialysis Patients

February 01, 2012

Research has shown that individuals who exercise have lower risk for chronic diseases than individuals who do not exercise.
 

Outdated Biases Deny Transplants to Older ESRD Patients

February 01, 2012

Thousands of older adults with end-stage renal disease are not receiving kidney transplants because of outdated medical biases, according to a new study.
 

Treatment of Lupus in ESRD Patients Beneficial

October 25, 2011

Close supervision by rheumatologists and the use of immunosuppressant drugs appear to improve the survival of lupus patients with end-stage renal disease. John Schieszer reports in today's Medical Minute that this new research finding could reverse a long-standing clinical practice for nephrologists.
 

ESRD Population Continues to Rise

October 24, 2011

As of December 31, 2009, the United States had 571,414 end-stage renal disease (ESRD) patients, up 3.8% from 549,265 patients a year before, according to the 2011 U.S. Renal Data System Annual Data Report.
 

Two RRT Modalities Offer Similar Survival

October 01, 2011

PRAGUE—Two forms of renal replacement therapy (RRT) for end-stage renal disease are associated with similar rates of mortality overall and from cardiovascular (CV) causes, according to a new study.
 

High Serum Phosphate May Advance CKD

October 01, 2011

Those with phosphate levels in the highest two quartiles progressed significantly faster either to end-stage renal disease (ESRD) or to a composite endpoint of a doubling of serum creatinine.
 

Treating SLE in ESRD May Boost Survival

September 19, 2011

Frequent follow-up with a rheumatologist and continued immunosuppressive treatment for systemic lupus erythematosus (SLE) in patients with end-stage renal disease (ESRD) improves their chances of survival, according to a study.
 

Persistent Hematuria in Kids Portends ESRD

September 09, 2011

End-stage renal disease (ESRD) is more likely to develop in adolescents and young adults with persistent microscopic hematuria, according to a report in the Journal of the American Medical Association (2011;306:729-736).
 

ESRD Payment System Changes Proposed

August 10, 2011

The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule that would update payment policies and rates under the End-Stage Renal Disease (ESRD) Prospective Payment System.
 

FGF-23, Mortality Linked Even in Early-Stage CKD

July 12, 2011

Elevated levels of fibroblast growth factor 23 (FGF-23) is an independent risk factor for end-stage renal disease (ESRD) in patients with relatively preserved kidney function and for mortality across the spectrum of chronic kidney disease (CKD).
 

Study: PD Patients Receive Kidney Transplants Sooner

June 28, 2011

PRAGUE—End-stage renal disease patients who start on peritoneal dialysis (PD) rather than hemodialysis (HD) spend less time on a renal transplant waiting list before getting a kidney, new findings suggest.
 

ACE Inhibitor Reduces ESRD Risk Among Obese Patients

June 16, 2011

Ramipril can essentially abolish the excess risk for end-stage renal disease (ESRD) seen in obese persons with chronic kidney disease (CKD), according to a post hoc analysis of the Ramipril Efficacy in Nephropathy (REIN) trial.
 

Drug Shows Promise for Treating Calciphylaxis

April 30, 2011

LAS VEGAS—Sodium thiosulfate may hold promise as a treatment for calciphylaxis in patients with end-stage renal disease (ESRD), researchers reported here at the National Kidney Foundation's Spring Clinical Meetings.
 

Vitamin D Repletion May Reduce Darbepoetin Requirements

April 28, 2011

LAS VEGAS—Vitamin D repletion in patients with end-stage renal disease maintains hemoglobin (Hb) levels and results in decreased requirement of darbepoetin alfa, according to data presented at the National Kidney Foundation's Spring Clinical Meetings.
 

Predictive Model for Progression of CKD to Kidney Failure

April 27, 2011

Clinicians may have an important new tool they can use to better predict which patients with chronic kidney disease (CKD) will progress to kidney failure.
 

Bundled ESRD Payments May Thwart Innovation

April 10, 2011

VANCOUVER, B.C.—The federal government's new system of bundled payments for end-stage renal disease (ESRD) care—which went into effect in January—may be stifling development of new ESRD therapies, according to investigators.
 

IgA Nephropathy: An Update on Diagnosis and Management

By Richard J. Glassock, MD, MACP April 01, 2011

Following a renal biopsy diagnosis of IgA nephropathy, clinicians need to estimate prognosis and design an appropriate short- and long-term treatment strategy.
 

Mammograms May Be Helpful in Detecting Heart Disease

February 14, 2011

Mammograms may be helpful in detecting heart disease in women with end-stage renal disease. John Schieszer has that story in today's Medical Minute.
 

Investigators Developing Biological Artificial Kidneys

February 08, 2011

Investigators in Holland are working on biological artificial kidneys.
 

Saliva Test Identifies Hypogonadism in ESRD Patients

February 07, 2011

Salivary testosterone (Sal-T) can be used to diagnose androgen deficiency reliably in men with end-stage renal disease (ESRD), according to a Brazilian study.
 

High Phosphocalcic Product May Rule Out Transplants

November 20, 2010

A high phosphocalcic product significantly increases the risk of non- eligibility for a kidney transplant among adults with end-stage renal disease (ESRD), Canadian researchers concluded in a study presented at Renal Week 2010 in Denver.
 

Elderly Men with CKD Are at Greater Death Risk

November 20, 2010

Among elderly patients with CKD, female gender and lower estimated glomerular filtration rate (eGFR) predict a higher risk of progressing to end-stage renal disease (ESRD), whereas male gender and a history of peripheral vascular disease are associated with an increased likelihood of death, according to a study presented at Renal Week 2010 in Denver.
 

Predialysis IV Iron Provides Superior Hemoglobin Control

November 19, 2010

Patients with end-stage renal disease who receive predialysis intravenous iron therapy are more likely to start hemodialysis with higher hemoglobin (Hb) levels and to achieve better Hb control better compared with patients treated with oral iron prior to dialysis initiation, French researchers reported at Renal Week 2010 in Denver.
 
Popular Topics
Acute Kidney Injury AKI Androgen Deprivation Anemia Benign Prostatic Hyperplasia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease Circumcision CKD CVD Diabetes Dialysis End-stage Renal Disease Hemodialysis Kidney Cancer Overactive Bladder Prostate Cancer Renal Cell Carcinoma Reproductive Medicine Secondary Hyperparathyroidism Transplantation Urinary Incontinence Urology

 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions